# Atrium Therapeutics to Present Nonclinical Data Showing ATR 1072 Reversed and Improved Features of PRKAG2 Syndrome During HCMS at AHA Scientific Sessions 2026

- Source: PR Newswire M&A
- Published: 2026-11-02T11:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/atrium-therapeutics-to-present-nonclinical-data-showing-atr-1072-reversed-and-improved-features-of-prkag2-syndrome-during-hcms-at-aha-scientific-sessions-2026-302925582.html
- Canonical: https://groundlevelnews.com/story/atrium-therapeutics-to-present-nonclinical-data-showing-atr-1072-rever-e3c202/

-- ATR 1072 impacted key characteristics of PRKAG2 syndrome, including accumulation of cardiac glycogen and cardiac hypertrophy -- -- Data further reinforce scientific rationale for ATR 1072 targeting the root cause of PRKAG2 syndrome -- -- Poster presentation November 6 at 5:30 p.m. CT...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._